dr. sznol discusses the importance of clinical trials in rcc
Published 6 years ago • 27 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
1:15
dr. sznol discusses advancements in immunotherapy for rcc
-
1:05
dr. sznol discusses immunotherapy combinations in rcc
-
1:02
dr. sznol on immunotherapy in patients with rcc
-
1:29
dr. sznol on unanswered questions with immunotherapy in rcc
-
0:50
dr. sznol discusses immunotherapy in non-clear cell renal cancer
-
29:39
precision medicine in nephrolog, prof hussein sheashaa, 7 oct 2020
-
10:28
responses to traditional chemotherapy vs immunotherapy
-
31:55
kidney cancer and immunotherapy with dr. saby george
-
1:22
dr. sznol discusses the combination of ipilimumab and nivolumab in melanoma
-
0:53
dr. mario sznol describes nivolumab in advanced melanoma
-
3:47
other clinical trials in renal cell carcinoma
-
1:25
dr. sznol on patient selection for combination therapy in mrcc
-
0:56
dr. sznol on the use of immunotherapy in melanoma
-
0:43
dr. pal on sequencing nivolumab in rcc
-
1:17
dr. sznol on immunotherapy combinations for the treatment of melanoma
-
1:05
dr. pal on potential tivozanib-based combinations in rcc
-
1:00
dr. sznol on immune-related toxicities in melanoma
-
1:47
dr. sznol on combining nivolumab and ipilimumab for the treatment of advanced melanoma
-
8:57
introduction and review of the comparz trial in renal cell carcinoma
-
6:36
frontline clinical trials in renal cell carcinoma
-
1:59
dr. sznol on combining nivolumab and ipilimumab for the treatment of advanced melanoma
-
1:17
dr. hammers on the future of immunotherapy in rcc